Safety and Tolerability Study of Rifaximin in Participants With a History of Hepatic Encephalopathy

Birmingham

Aurora

Fresno

La Jolla

Long Beach

Los Angeles

Merced

Sacramento

San Francisco

Golden

Washington D.C.

Macon

Iowa City

Monroe

Boston

Detroit

Kansas City

Lebanon

Bayside

New York

Rochester

Asheville

Charlotte

Cincinnati

Cleveland

Philadelphia

Houston

Odessa

San Antonio

Richmond

Madison

Calgary

Victoria

Toronto

Montreal